Published in Ann Otol Rhinol Laryngol on January 01, 2001
Primary leiomyoma of the trachea, bronchus, and pulmonary parenchyma--a single-institutional experience. Eur J Cardiothorac Surg (2012) 1.32
Carcinoid and mucoepidermoid bronchial tumours in children. Eur J Pediatr (2005) 0.97
Childhood and adolescent tracheobronchial mucoepidermoid carcinoma (MEC): a case-series and review of the literature. Pediatr Surg Int (2016) 0.77
A benign sessile endobronchial leiomyoma in a 2-year-old girl with human immunodeficiency virus (HIV). Ann Otol Rhinol Laryngol (2002) 0.75
Perspectives on the basic reproductive ratio. J R Soc Interface (2005) 5.34
Value-based pathology: a cost-benefit analysis of the examination of routine and nonroutine tonsil and adenoid specimens. Am J Clin Pathol (1997) 4.51
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther (1990) 3.55
Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet (2000) 3.48
Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet (1997) 2.82
The gut: a central organ after surgical stress. Surgery (1988) 2.76
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest (1995) 2.66
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA (1999) 2.56
Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52
Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet (2001) 2.48
Interaction between the Rous sarcoma virus transforming protein and two cellular phosphoproteins: analysis of the turnover and distribution of this complex. Mol Cell Biol (1983) 2.46
Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35
Broadband observations of the naked-eye gamma-ray burst GRB 080319B. Nature (2008) 2.16
A re-examination of risk estimates from the NIOSH Occupational Noise and Hearing Survey (ONHS) J Acoust Soc Am (1997) 2.09
Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07
Oral challenge tests for urticaria--an ethical dilemma. Br J Dermatol (1994) 1.98
Pattern formation in the blue-green alga, Anabaena. I. Basic mechanisms. J Cell Sci (1973) 1.92
Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest (1998) 1.91
Rous sarcoma virus-induced phosphorylation of a 50,000-molecular weight cellular protein. Nature (1982) 1.90
Analysis of the catalytic domain of phosphotransferase activity of two avian sarcoma virus-transforming proteins. J Biol Chem (1984) 1.90
Camptodactyly and simialr atraumatic flexion deformities of the proximal interphalangeal joints of the fingers. A study of thirty-one cases. J Bone Joint Surg Am (1968) 1.89
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet (1999) 1.82
Eye signs in craniopharyngioma. Br J Ophthalmol (1975) 1.80
Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med (2001) 1.78
Pattern formation in the blue-green alga Anabaena. II. Controlled proheterocyst regression. J Cell Sci (1973) 1.78
Recurrent meningitis and Mondini dysplasia. Arch Otolaryngol Head Neck Surg (1990) 1.77
Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat (2001) 1.77
Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76
Glutamine metabolism by the intestinal tract. JPEN J Parenter Enteral Nutr (1985) 1.71
Teratogenicity of 2-ethoxyethanol by dermal application. Drug Chem Toxicol (1982) 1.70
Localization of the Usher syndrome type ID gene (Ush1D) to chromosome 10. Hum Mol Genet (1996) 1.69
Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg Am (1981) 1.69
Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med (1992) 1.68
Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum Mol Genet (2001) 1.68
Challenge test battery in chronic urticaria. Br J Dermatol (1976) 1.67
Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med (1999) 1.67
Localization of Usher syndrome type II to chromosome 1q. Genomics (1990) 1.67
A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg (1988) 1.66
Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3':5'-monophosphate and calcium in stimulus-secretion coupling. Proc Natl Acad Sci U S A (1975) 1.65
Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet (1998) 1.63
Why retrobulbar anaesthesia? Br J Ophthalmol (1988) 1.63
Mutants of Anabaena cylindrica altered in heterocyst spacing. Arch Microbiol (1975) 1.62
A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment. J Med Genet (2001) 1.61
Related cell-surface antigens expressed with positional specificity in Drosophila imaginal discs. Proc Natl Acad Sci U S A (1984) 1.60
Ten per cent polarized optical emission from GRB 090102. Nature (2009) 1.58
Highly polarized light from stable ordered magnetic fields in GRB 120308A. Nature (2013) 1.57
Performance of a whole-body PET scanner using curve-plate NaI(Tl) detectors. J Nucl Med (2001) 1.56
Giant-cell tumors of the bones of the hand. J Hand Surg Am (1980) 1.55
Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet (1999) 1.54
Increased intestinal permeability associated with infection in burn patients. Arch Surg (1988) 1.53
Abnormal movement of the arytenoid region during exercise presenting as exercise-induced asthma in an adolescent athlete. Chest (1994) 1.52
Behavioral changes correlated with brain-stem auditory evoked responses in term infants with moderate hyperbilirubinemia. J Pediatr (1990) 1.50
ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem Biophys Res Commun (1994) 1.48
The Lang lecture 1986. The enigma of primary open-angle glaucoma. Trans Ophthalmol Soc U K (1986) 1.48
Allometric scaling in comparative biology: problems of concept and method. Am J Physiol (1984) 1.48
[ The family physician's sentinel function studied with reference to referrals and referral cards]. Ned Tijdschr Geneeskd (1996) 1.47
Organic dust toxicity (pulmonary mycotoxicosis) associated with silo unloading. Thorax (1986) 1.46
Pyrazoline bisphosphonate esters as novel antiinflammatory and antiarthritic agents. J Med Chem (1993) 1.45
Management of congenital buccopharyngeal membrane. Cleft Palate Craniofac J (1997) 1.39
Study finds sleeping pills overprescribed. Science (1979) 1.39
Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J Biol Chem (1998) 1.37
Linkage of a gene for dominant non-syndromic deafness to chromosome 19. Hum Mol Genet (1995) 1.36
A position-specific cell surface antigen in the drosophila wing imaginal disc. Cell (1981) 1.35
Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. Am J Psychiatry (2001) 1.35
Rethinking allometry. J Theor Biol (1980) 1.34
Molecular analysis of the mitochondrial 12S rRNA and tRNASer(UCN) genes in paediatric subjects with non-syndromic hearing loss. J Med Genet (2004) 1.34
Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells. J Biol Chem (1985) 1.33
Two frequent missense mutations in Pendred syndrome. Hum Mol Genet (1998) 1.31
Phorbol myristate acetate-induced release of granule enzymes from human neutrophils: inhibition by the calcium antagonist, 8-(N,N-diethylamino)-octyl 3,4,5-trimethoxybenzoate hydrochloride. Biochem Biophys Res Commun (1979) 1.31
Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet (2000) 1.30
Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection. J Infect Dis (1982) 1.30
Genetic heterogeneity of Usher syndrome: analysis of 151 families with Usher type I. Am J Hum Genet (2000) 1.29
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med (1999) 1.28
Excretion of cytomegalovirus in mothers: observations after delivery of congenitally infected and normal infants. J Infect Dis (1982) 1.27
Pediatric otolaryngologists' knowledge and understanding of genetic testing for deafness. Arch Otolaryngol Head Neck Surg (2001) 1.26
Laryngomalacia and its treatment. Laryngoscope (1999) 1.26
Use of isolated nuclei in the indirect fluorescent-antibody test for human cytomegalovirus infection: comparison with microneutralization, anticomplement, and conventional indirect fluorescent-antibody assays. J Clin Microbiol (1978) 1.25
High prevalence of symptoms of Menière's disease in three families with a mutation in the COCH gene. Hum Mol Genet (1999) 1.25
Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva. J Infect Dis (1993) 1.24
Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle. Am J Physiol (1995) 1.24
Maintenance of small bowel mucosa with glutamine-enriched parenteral nutrition. JPEN J Parenter Enteral Nutr (1990) 1.23
Mood effects on limbic blood flow correlate with emotional self-rating: a PET study with oxygen-15 labeled water. Psychiatry Res (1995) 1.21
Identification of mutations in the connexin 26 gene that cause autosomal recessive nonsyndromic hearing loss. Hum Mutat (1998) 1.21
Imported yellow fever in a United States citizen. Clin Infect Dis (1997) 1.20
Health and economic implications of a work-site smoking-cessation program: a simulation analysis. J Occup Environ Med (1996) 1.19
The glutamate dehydrogenase gene of Clostridium symbiosum. Cloning by polymerase chain reaction, sequence analysis and over-expression in Escherichia coli. Eur J Biochem (1992) 1.18
Purification, properties, and subcellular localization of foxtail mosaic potexvirus 26-kDa protein. Virology (1994) 1.18
Induction of labour at term. Women not for waiting. BMJ (1993) 1.18
Interface fluid after LASIK: misleading tonometry can lead to end-stage glaucoma. J Cataract Refract Surg (2000) 1.18
A new tissue adhesive for laceration repair in children. J Pediatr (1998) 1.17
Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15. Hum Mol Genet (1995) 1.17
Evaluation of a microtiter plate fluorescent-antibody assay for rapid detection of human cytomegalovirus infection. J Clin Microbiol (1992) 1.16
Calmodulin and calcium mediated regulation in prokaryotes. J Gen Microbiol (1992) 1.16
Safety and metabolic effects of L-glutamine administration in humans. JPEN J Parenter Enteral Nutr (1990) 1.16
Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest (1993) 1.15
Parental attitudes toward genetic testing for pediatric deafness. Am J Hum Genet (2000) 1.15
Prevention of experimental bovine pneumonic pasteurellosis with an extract of Pasteurella haemolytica. Can J Comp Med (1983) 1.14
Addition of timolol maleate to routine medical therapy: a clinical trial. Br J Ophthalmol (1980) 1.14
Multiple signalling pathways trigger the exquisite sensitivity of yeast gluconeogenic mRNAs to glucose. Mol Microbiol (1996) 1.14